Curis Inc (CRIS) income statement
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3094% below fair value
$0.43−0.04 (-9.03%)
Close on Nov 20, 2026Market cap $892.46KP/E –Yield –
Curis Inc financial ratios
See a number that looks wrong?